July 14 (Reuters) - Pharmaxis Ltd PXS.AX :
* FDA GRANTS ORPHAN DRUG STATUS FOR PHARMAXIS ANTI FIBROTIC DRUG FOR MYELOFIBROSIS
July 14 (Reuters) - Pharmaxis Ltd PXS.AX :
* FDA GRANTS ORPHAN DRUG STATUS FOR PHARMAXIS ANTI FIBROTIC DRUG FOR MYELOFIBROSIS